|Bid||360.37 x 1100|
|Ask||360.98 x 1100|
|Day's range||359.67 - 361.40|
|52-week range||298.69 - 401.78|
|Beta (5Y monthly)||0.61|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||2.16 (0.60%)|
|Ex-dividend date||28 Feb 2023|
|1y target est||N/A|
McKesson (MCK) closed at $354.48 in the latest trading session, marking a +1.45% move from the prior day.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
McKesson (NYSE: MCK), a healthcare supplier that was founded in 1833, is a value investor's dream. The company has seen its shares rise more than 15% over the past year, though they have fallen more than 7% so far in 2023. McKesson recently raised its guidance for fiscal 2023, citing operational momentum.